13F reference period
Q3 2026
Security Snapshot
Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA) Institutional Ownership
CUSIP: 05153U107
13F Institutional Holders and Ownership History from Q4 2021 to Q3 2026
Institutions Reporting
72
Shares (Excl. Options)
24.33M
Full value: 24,334,114 · shares · 30 Sep 2026Price
$6.28
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.00001 per share
- Symbol
- AURA on Nasdaq
- All holders as of 30 Sep 2026
- Q3 2026
- Total 13F shares
- 24,334,114
- Total 13F value
- $153,591,731
- Portfolio coverage rank
- 0%
- Share change
- +2,271,918
- Value change
- +$13,659,009
- Number of holders
- 72
- Shares outstanding
- 102,550,724
- SEC-reported price per share
- $6.27
- Insider filing price
- $6.27
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- AURA - Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share is tracked under CUSIP 05153U107.
- 72 institutions reported positions in Q3 2026.
- 8 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 146 to 72 between Q2 2026 and Q3 2026.
- SEC-reported value moved from to
$677.25M
Full value: $677,249,273 · USD · 30 Jun 2026.$153.59M
Full value: $153,591,731 · USD · 30 Sep 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 72 institutions filings for Q3 2026.
Security key
05153U107
13F reference period
Q3 2026
13F holders
72
13D/G owners
8
CIK / CUSIP context first
Open Q3 2026 holders
AURA full holder history
Aura Biosciences, Inc. SEC filings
Aura Biosciences, Inc. company facts
Aura Biosciences, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 05153U107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
8
Security
AURA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| TCG Crossover GP II, LLC | 9.9% | $64,540,664 | 9,533,333 | Chen Yu | 05 May 2026 | |||
| Adage Capital Management, L.P. | 8.4% | $64,640,487 | 9,104,294 | Adage Capital Management, L.P. | 30 Jun 2026 | |||
| Frazier Life Sciences Public Fund, L.P. | 5.6% | -12% | $41,231,546 | +$12,603,920 | 5,807,260 | +44% | Frazier Life Sciences Public Fund, L.P. | 30 Jun 2026 |
| ForGrowth III PA B.V. | 5.1% | $38,841,423 | 5,248,841 | ForGrowth III PA B.V. | 25 Sep 2026 | |||
| BlackRock, Inc. | 5% | +16% | $32,786,239 | +$4,001,667 | 5,219,492 | +14% | BlackRock, Inc. | 30 Sep 2026 |
| Long Focus Capital Management, LLC | 4.9% | -24% | $36,349,032 | +$12,780,000 | 5,119,582 | +54% | LONG FOCUS CAPITAL MANAGEMENT, LLC | 30 Jun 2026 |
| MONTANOVA CAPITAL, LLC | 2.9% | -59% | $18,646,798 | -$10,833,331 | 2,973,971 | -37% | Montanova Capital, LLC | 30 Sep 2026 |
| Advent Life Sciences LLP | 3.3% | $11,768,148 | 2,071,857 | Rajesh Parekh, Ph.D. | 13 Feb 2026 |
As of 30 Sep 2026,
72
institutional investors reported holding
shares of
Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA).
This represents
24%
of the company’s total
outstanding shares.
24.33M
Full value: 24,334,114 · shares · 30 Sep 2026102.55M
Full value: 102,550,724 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
23%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 3.9% | 3,952,319 | -3.6% | 0% | $24,820,563 |
| Nantahala Capital Management, LLC | 3.7% | 3,807,300 | +29% | 1.3% | $23,909,844 |
| Medicxi Ventures Management (Jersey) Ltd | 3% | 3,039,892 | 0% | 15% | $19,090,522 |
| STATE STREET CORP | 2.2% | 2,301,520 | +88% | 0% | $14,453,546 |
| FRANKLIN TEMPLETON INC | 2% | 2,082,287 | +0.46% | 0% | $13,847,209 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 1,944,737 | +11% | 0% | $12,216,885 |
| Vivo Capital, LLC | 1.1% | 1,166,667 | 0% | 0.81% | $7,326,669 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.92% | 942,724 | +8.2% | 0% | $5,920,307 |
| LEVIN CAPITAL STRATEGIES, L.P. | 0.81% | 826,834 | -1.3% | 0.37% | $5,192,523 |
| DIMENSIONAL FUND ADVISORS LP | 0.69% | 708,950 | +15% | 0% | $4,450,866 |
| VANGUARD FIDUCIARY TRUST CO | 0.62% | 633,162 | -0.63% | 0% | $3,976,257 |
| Regency Capital Management Inc.\DE | 0.52% | 533,068 | -1.4% | 1.4% | $3,347,667 |
| Qube Research & Technologies Ltd | 0.27% | 272,145 | +148% | 0% | $1,709,071 |
| Jump Financial, LLC | 0.21% | 218,933 | +200% | 0.01% | $1,374,899 |
| Quantinno Capital Management LP | 0.21% | 216,918 | +66% | 0% | $1,362,245 |
| MORGAN STANLEY | 0.19% | 196,808 | +13% | 0% | $1,235,955 |
| Y-Intercept (Hong Kong) Ltd | 0.17% | 174,121 | 0.02% | $1,093,480 | |
| BNP PARIBAS FINANCIAL MARKETS | 0.14% | 142,574 | 0% | $895,365 | |
| RENAISSANCE TECHNOLOGIES LLC | 0.14% | 140,084 | -20% | 0% | $879,728 |
| Fisher Asset Management, LLC | 0.08% | 83,508 | 0% | 0% | $524,430 |
| WATER ISLAND CAPITAL LLC | 0.07% | 72,500 | +21% | 0.05% | $455,300 |
| MARTINGALE ASSET MANAGEMENT L P | 0.07% | 71,258 | 0% | 0.01% | $447,501 |
| Invesco Ltd. | 0.06% | 63,107 | +41% | 0% | $396,312 |
| TBH Global Asset Management, LLC | 0.06% | 60,322 | 0% | 0.08% | $378,824 |
| AMERICAN CENTURY COMPANIES INC | 0.05% | 54,717 | 0% | $343,623 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
20
Headline period
Q3 2026
Rows shown
1-20 of 20
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 24,334,114 | $153,591,731 | +$13,659,009 | $6.28 | 72 |
| 2026 Q2 | 95,385,877 | $677,249,273 | +$301,096,905 | $7.10 | 146 |
| 2026 Q1 | 50,880,612 | $340,347,350 | +$4,373,812 | $6.69 | 125 |
| 2025 Q4 | 50,234,935 | $273,791,080 | -$8,935,762 | $5.45 | 116 |
| 2025 Q3 | 51,649,516 | $319,192,259 | +$6,254,107 | $6.18 | 106 |
| 2025 Q2 | 50,616,053 | $316,863,119 | +$67,408,487 | $6.26 | 102 |
| 2025 Q1 | 39,264,901 | $230,096,030 | -$11,860,142 | $5.86 | 91 |
| 2024 Q4 | 39,449,434 | $324,276,778 | +$16,157,250 | $8.22 | 93 |
| 2024 Q3 | 36,866,668 | $329,191,609 | -$25,783,402 | $8.91 | 81 |
| 2024 Q2 | 39,765,227 | $300,437,451 | +$3,314,060 | $7.56 | 75 |
| 2024 Q1 | 39,115,323 | $307,072,789 | +$16,222,241 | $7.85 | 77 |
| 2023 Q4 | 36,998,812 | $327,811,496 | +$89,731,106 | $8.86 | 71 |
| 2023 Q3 | 26,323,010 | $236,119,190 | -$5,574,466 | $8.97 | 62 |
| 2023 Q2 | 27,066,492 | $334,426,517 | +$24,980,886 | $12.35 | 59 |
| 2023 Q1 | 25,069,599 | $232,645,346 | +$10,922,124 | $9.28 | 57 |
| 2022 Q4 | 23,806,818 | $250,037,016 | +$78,469,205 | $10.50 | 49 |
| 2022 Q3 | 16,317,002 | $295,663,462 | +$9,714,465 | $18.12 | 43 |
| 2022 Q2 | 15,793,428 | $223,796,376 | +$29,644,466 | $14.17 | 42 |
| 2022 Q1 | 13,702,730 | $298,756,000 | +$9,092,301 | $22.00 | 34 |
| 2021 Q4 | 13,081,587 | $220,131,000 | +$220,131,000 | $16.98 | 32 |